TipRanks
Go Ultimate55% OFF

Xbrane Biopharma AB (XBRANE) Balance Sheet

Xbrane Biopharma AB Balance Sheet

Xbrane Biopharma AB's total assets for Q3 2026 were $618.36M, a decrease of 3.77% from the previous quarter. SE:XBRANE total liabilities were $91.21M for the fiscal quarter, a 12.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 671.62M$ 842.43M$ 653.51M$ 690.51M$ 688.43M
$ 110.97M$ 633.89M$ 482.17M$ 265.63M$ 256.69M
$ 560.65M$ 208.54M$ 171.34M$ 424.89M$ 431.74M

Currency in SEK

Xbrane Biopharma AB Debt to Assets

0300M600M900M0 %30 %60 %90 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets